Vertex Pharmaceuticals (VRTX) Prepaid Assets (2009 - 2026)

Vertex Pharmaceuticals has reported Prepaid Assets for 18 years, with the latest figure at $791.9 million in Q2 2026.

• On a quarterly basis, Prepaid Assets rose 21.4% year-over-year to $791.9 million in Q2 2026; TTM through Jun 2026 was $791.9 million, a 21.4% increase from a year earlier, with the FY2025 full-year figure at $853.3 million, up 28.18% from the prior year.
• Prepaid Assets was $791.9 million for Q2 2026 at Vertex Pharmaceuticals, up from $720.8 million in the prior quarter.
• The five-year high for Prepaid Assets was $853.3 million in Q4 2025, with the low at $449.2 million in Q3 2024.
• Average Prepaid Assets over 5 years is $611.3 million, with a median of $599.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 58.77% in 2022, then retreated 25.68% in 2023.
• Over 5 years, Prepaid Assets stood at $553.5 million in 2022, then rose by 12.68% to $623.7 million in 2023, then gained by 6.73% to $665.7 million in 2024, then gained by 28.18% to $853.3 million in 2025, then retreated by 7.2% to $791.9 million in 2026.
• The last three Prepaid Assets figures came in at $791.9 million (Q2 2026), $720.8 million (Q1 2026), and $853.3 million (Q4 2025), per Business Quant data.